Thank you, Madam Chair.
I would like to ask an additional question of Ms. Boudreau. My question has to do with the Patented Medicine Prices Review Board. I noticed that there has been a $704,000 increase over the year 2009-2010, in other words a little over 10%, raising the amount to $7.75 million for the current fiscal year.
What is the rationale behind this increase? What do you say to individuals and organizations that believe that the Patented Medicine Prices Review Board is exceeding its mandate?